|
Market Closed -
Bombay S.E.
06:02:21 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 6.340 INR | +5.32% |
|
+0.63% | -22.11% |
| Market Cap | 376M 3.93M 3.39M 3.18M 2.9M 5.47M 5.48M 37.72M 14.72M 190M 14.77M 14.45M 629M | P/E 2024 |
-10.3x | P/E 2025 | -13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 443M 4.63M 3.99M 3.74M 3.42M 6.44M 6.46M 44.41M 17.33M 224M 17.39M 17.02M 741M | EV / Sales 2024 |
7.63x | EV / Sales 2025 | 8.85x |
| Free-Float |
22.51% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.32% | ||
| 1 week | +0.63% | ||
| Current month | -4.37% | ||
| 1 month | -10.96% | ||
| 3 months | -20.75% | ||
| 6 months | -8.12% | ||
| Current year | -22.11% |
| 1 week | 5.86 | 7.28 | |
| 1 month | 5.81 | 7.33 | |
| Current year | 5.71 | 8.87 | |
| 1 year | 5.71 | 10.75 | |
| 3 years | 5.71 | 19.7 | |
| 5 years | 5.71 | 19.7 | |
| 10 years | 4.51 | 56.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Murali Meraga
CEO | Chief Executive Officer | - | - |
Suneel Pachipala
DFI | Director of Finance/CFO | - | - |
Barkha Jain
CMP | Compliance Officer | - | 2024-02-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Dhananjaya Alli
CHM | Chairman | 76 | 2014-01-01 |
| Director/Board Member | 87 | 1993-06-15 | |
| Director/Board Member | 76 | 2010-02-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.32% | +0.63% | -39.04% | -51.04% | 3.88M | ||
| +0.35% | +0.84% | +19.98% | +73.55% | 48.07B | ||
| -0.08% | -0.21% | +55.27% | +121.68% | 40.17B | ||
| +0.15% | +7.52% | +20.56% | +89.26% | 12.42B | ||
| +0.25% | -1.01% | -9.89% | +17.70% | 12.01B | ||
| +0.19% | +0.19% | +30.98% | +150.00% | 9.38B | ||
| +0.07% | +3.80% | +27.09% | +45.88% | 7.78B | ||
| +0.04% | +0.37% | +48.15% | -11.95% | 7.24B | ||
| +2.24% | +7.81% | +28.93% | +240.12% | 7.27B | ||
| -0.53% | -1.53% | -34.29% | +19.67% | 5.33B | ||
| Average | +0.80% | +0.88% | +14.77% | +69.49% | 14.97B | |
| Weighted average by Cap. | +0.23% | +0.25% | +28.02% | +88.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103M 1.08M 928K 870K 794K 1.5M 1.5M 10.32M 4.03M 51.93M 4.04M 3.95M 172M | 101M 1.05M 908K 852K 777K 1.46M 1.47M 10.1M 3.94M 50.86M 3.96M 3.87M 169M |
| Net income | -45.12M -472K -407K -381K -348K -656K -658K -4.53M -1.77M -22.78M -1.77M -1.73M -75.52M | -46.49M -486K -419K -393K -359K -676K -678K -4.66M -1.82M -23.47M -1.83M -1.79M -77.81M |
| Net Debt | 78.7M 823K 710K 665K 607K 1.14M 1.15M 7.89M 3.08M 39.73M 3.09M 3.02M 132M | 66.71M 698K 601K 564K 515K 970K 973K 6.69M 2.61M 33.68M 2.62M 2.56M 112M |
Employees
30
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | ₹6.340 | +5.32% | 8,559 |
| 26-08-27 | ₹6.020 | -0.17% | 17,294 |
| 26-08-26 | ₹6.030 | -10.13% | 49,500 |
| 26-08-25 | ₹6.710 | +1.82% | 35,581 |
| 26-08-24 | ₹6.590 | +2.33% | 38,083 |
- Stock Market
- Stocks
- VISTAPH6 Stock
Select your edition
All financial news and data tailored to specific country editions
















